title: Discrepancies of applying primary myelofibrosis prognostic scores for patients with post polycythemia vera/essential thrombocytosis myelofibrosis.
authors.affiliation: Mayo Clinic Arizona, Department of Hematology, Scottsdale, AZ, USA.
authors.forename: Krisstina
authors.initials: K
authors.lastname: Gowin
authors.affiliation: Department of Medical Oncology, Cork University Hospital, Wilton, Ireland.
authors.forename: Maria
authors.initials: M
authors.lastname: Coakley
authors.affiliation: Mayo Clinic Arizona, Department of Health Sciences Research, Section of Biostatistics, Scottsdale, AZ, USA.
authors.forename: Heidi
authors.initials: H
authors.lastname: Kosiorek
authors.affiliation: Mayo Clinic Arizona, Department of Hematology, Scottsdale, AZ, USA Mesa.ruben@mayo.edu.
authors.forename: Ruben
authors.initials: R
authors.lastname: Mesa
mesh_terms: D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D001772:Blood Cell Count / Q000592:standards; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D011087:Polycythemia Vera / Q000097:blood* / Q000175:diagnosis*; D055728:Primary Myelofibrosis / Q000097:blood* / Q000175:diagnosis*; D011379:Prognosis; D012189:Retrospective Studies; D012307:Risk Factors; D013920:Thrombocythemia, Essential / Q000097:blood* / Q000175:diagnosis*
keywords: post essential thrombocytosis myelofibrosis; post polycythemia vera; primary myelofibrosis; prognostic scores